The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests
- PMID: 2732616
The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests
Abstract
Monoclonal antibody DD/3B6 reacts with a site near the gamma gamma isopeptide cross link and has been used to detect cross-linked fibrin degradation products in plasma as a marker for clot lysis. However, interpretation of the results is potentially complicated, because soluble cross-linked fibrin polymers contain a gamma gamma cross-link and may also react with the antibody before or after plasmic degradation. We have prepared plasmic digests of fibrinogen, soluble cross-linked fibrin polymers, and cross-linked particulate fibrin clot, have characterized their composition by electrophoresis, and have compared their D dimer immunoreactivities. Undegraded soluble cross-linked fibrin polymer showed no reactivity below 20 micrograms/ml, indicating that the epitope recognized by DD/3B6 is poorly reactive before plasmic degradation. The D dimer immunoreactivity of plasmic digests of particulate or of soluble cross-linked fibrin increased with progressive degradation, with stage 3 digests having 20-fold to 40-fold higher immunoreactivity than stage 1 digests. A stage 3 digest of fully cross-linked particulate fibrin reacted fourfold and 10-fold more than stage 3 digests of soluble fibrin polymers and untreated fibrinogen, which contained 21% and 8.5% soluble fibrin, respectively. Thus, D dimer immunoreactivity in stage 3 digests correlated with the amount of soluble cross-linked fibrin polymer in the undegraded starting material. These findings demonstrate that degradation of soluble or particulate cross-linked fibrin increases D dimer immunoreactivity progressively, with maximal reaction attained with stage 3 digests.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Reactivity of soluble fibrin assays with plasmic degradation products of fibrin and in patients receiving fibrinolytic therapy.Thromb Haemost. 1999 Dec;82(6):1722-9. Thromb Haemost. 1999. PMID: 10613661
-
Validation, calibration, and specificity of quantitative D-dimer assays.Semin Vasc Med. 2005 Nov;5(4):315-20. doi: 10.1055/s-2005-922476. Semin Vasc Med. 2005. PMID: 16302152 Review.
-
The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.Thromb Res. 2007;121(3):377-85. doi: 10.1016/j.thromres.2007.05.008. Epub 2007 Jun 11. Thromb Res. 2007. PMID: 17561232
-
Reactivity of fibrinogen derivatives with antisera to human fibrin D-dimer and its gamma-gamma chain remnant.Thromb Haemost. 1982 Aug 24;48(1):33-7. Thromb Haemost. 1982. PMID: 7135342
-
Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.Semin Thromb Hemost. 2001 Dec;27(6):657-66. doi: 10.1055/s-2001-18870. Semin Thromb Hemost. 2001. PMID: 11740689 Review.
Cited by
-
Advances in D-dimer testing: progress in harmonization of clinical assays and innovative detection methods.Anal Bioanal Chem. 2024 Jul;416(16):3737-3750. doi: 10.1007/s00216-024-05207-x. Epub 2024 Mar 20. Anal Bioanal Chem. 2024. PMID: 38503987 Review.
-
Role of fibrin D-dimer testing in emergency medicine.Emerg Med J. 2003 Jul;20(4):319-25. doi: 10.1136/emj.20.4.319. Emerg Med J. 2003. PMID: 12835339 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources